Epidemiology and Prognosis of T-Cell Lymphoma
T/NK-cell lymphoid neoplasms account for approximately 6 % of all lymphoid neoplasms. While the incidence rates of many B-cell lymphomas have begun to decline in the United States (US) in recent years, incidence rates for T-cell lymphomas have continued to rise. The causes of the majority of T-cell lymphomas remain unexplained. T-cell lymphomas comprise multiple subtypes and their distinct descriptive epidemiology—e.g., striking differences between incidences of T-cell lymphoma subtypes by age, over time and by race/ethnicity—likely reflect their distinct etiologies (e.g., celiac disease and extranodal T-cell lymphomas; human T-cell lymphotropic virus I (HTLV-1) and adult T-cell leukemia/lymphoma). Differences in T-cell lymphoma subtypes further extend to their clinical characteristics and care; they each have differential treatment, survival and prognosis. The rarity of T-cell lymphomas has historically posed challenges for furthering our understanding of these tumors, particularly as we now understand that each T-cell lymphoma subtype requires investigation independently. However, we expect important clues to emerge as on-going large international consortium efforts aim to accrue sufficient sample sizes of T-cell lymphomas and its subtypes for both etiological and prognostic studies.
We thank J. Daniel Carreon for guidance on descriptive statistics and graphical presentation.
- 8.Wang SS, Slager SL, Brennan P, Holly EA, De SS, Bernstein L, et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;109:3479–88.PubMedCrossRefGoogle Scholar
- 23.International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risks to humans: Dry cleaning, some chlorinated solvents and other industrial chemicals. Lyon, France: International Agency for Research on Cancer;1995.Google Scholar